These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11512643)

  • 21. Hypnotics in infusion anaesthesia--with particular reference to thiopentone.
    Crankshaw DP
    Anaesth Intensive Care; 1987 Feb; 15(1):90-6. PubMed ID: 3551682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electroencephalographic effects of thiopentone and its enantiomers in the rat.
    Mather LE; Edwards SR; Duke CC
    Life Sci; 2000; 66(2):105-14. PubMed ID: 10666006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of burst suppression and bispectral index with 2 different bolus doses of thiopentone sodium.
    Ramesh VJ; Umamaheswara Rao GS
    J Neurosurg Anesthesiol; 2007 Jul; 19(3):179-82. PubMed ID: 17592349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pentobarbitone formation during thiopentone infusion.
    Chan HN; Morgan DJ; Crankshaw DP; Boyd MD
    Anaesthesia; 1985 Dec; 40(12):1155-9. PubMed ID: 4083444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complications and side effects during thiopentone therapy in patients with severe head injuries.
    Schalén W; Messeter K; Nordström CH
    Acta Anaesthesiol Scand; 1992 May; 36(4):369-77. PubMed ID: 1595344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central diabetes insipidus in pediatric severe traumatic brain injury.
    Alharfi IM; Stewart TC; Foster J; Morrison GC; Fraser DD
    Pediatr Crit Care Med; 2013 Feb; 14(2):203-9. PubMed ID: 23314181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A critical review: does thiopental continuous infusion warrant therapeutic drug monitoring in the critical care population?
    Huynh F; Mabasa VH; Ensom MH
    Ther Drug Monit; 2009 Apr; 31(2):153-69. PubMed ID: 19177032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of thiopental and pentobarbital enantiomers after intravenous administration of racemic thiopental.
    Nguyen KT; Stephens DP; McLeish MJ; Crankshaw DP; Morgan DJ
    Anesth Analg; 1996 Sep; 83(3):552-8. PubMed ID: 8780280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variability of thiopental clearance in routine critical care patients.
    Russo H; Brés J; Duboin MP; Roquefeuil B
    Eur J Clin Pharmacol; 1995; 48(6):479-87. PubMed ID: 8582467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracranial pressure response after pharmacologic treatment of intracranial hypertension.
    Colton K; Yang S; Hu PF; Chen HH; Bonds B; Scalea TM; Stein DM
    J Trauma Acute Care Surg; 2014 Jul; 77(1):47-53; discussion 53. PubMed ID: 24977754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of thiopentone and mannitol on cerebral perfusion pressure and E.E.G. in head injured patients with intracranial hypertension.
    Procaccio F; Menasce G; Sacchi L; Boselli L
    Agressologie; 1991; 32(8-9 Spec No):381-5. PubMed ID: 1844198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Individual variation in response to thiopentone.
    Christensen JH
    Dan Med Bull; 1989 Jun; 36(3):281-98. PubMed ID: 2666039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of high-dose thiopental in pediatric patients with increased intracranial pressure.
    Russo H; Bressolle F; Duboin MP
    Ther Drug Monit; 1997 Feb; 19(1):63-70. PubMed ID: 9029749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma and cerebrospinal fluid barbiturate levels during prolonged continuous thiopentone infusion.
    Airey IL; Smith PA; Stoddart JC
    Anaesthesia; 1982 Mar; 37(3):328-31. PubMed ID: 7091608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Life-threatening intracranial hypertension in Reye's syndrome treated with intravenous thiopentone.
    McWilliam RC; Stephenson JB
    Eur J Pediatr; 1985 Nov; 144(4):383-4. PubMed ID: 4076255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nocifensive reflex thresholds in rats: measures of central nervous system effects of barbiturates.
    Archer DP; Samanani N; Roth SH
    Can J Anaesth; 1997 Jul; 44(7):765-74. PubMed ID: 9232309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fentanyl and Midazolam Are Ineffective in Reducing Episodic Intracranial Hypertension in Severe Pediatric Traumatic Brain Injury.
    Welch TP; Wallendorf MJ; Kharasch ED; Leonard JR; Doctor A; Pineda JA
    Crit Care Med; 2016 Apr; 44(4):809-18. PubMed ID: 26757162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics and EEG effects of midazolam during and after 1-minute, 1-hour, and 3-hour intravenous infusions.
    Greenblatt DJ; Ehrenberg BL; Culm KE; Scavone JM; Corbett KE; Friedman HL; Harmatz JS; Shader RI
    J Clin Pharmacol; 2004 Jun; 44(6):605-11. PubMed ID: 15145968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time-dependent pharmacokinetics of high dose thiopental infusion in intensive care patients.
    Russo H; Dubboin MP; Bressolle F; Urien S
    Pharm Res; 1997 Nov; 14(11):1583-8. PubMed ID: 9434278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Life-threatening hyperkalaemia following therapeutic barbiturate coma.
    Cairns CJ; Thomas B; Fletcher S; Parr MJ; Finfer SR
    Intensive Care Med; 2002 Sep; 28(9):1357-60. PubMed ID: 12209290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.